# iShares Genomics Immunology and Healthcare ETF (IDNA)

> Source: Nexqual · https://nexqual.com/IDNA · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, iShares Genomics Immunology and Healthcare ETF (IDNA), nexqual.com/IDNA" · informational, not investment advice.

**Price:** USD 40.91 (-0.32% on the day) · last close of Oct 23, 2026; US market after hours, not a live price. Prev close 41.04 · day 40.14–41.15 · 52w 24.29–43.44 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +66.0% vs S&P 500 +13.4%; 5Y -13.7% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +66.0% | -13.7% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +66.3% | -2.9% |
| Volatility (annualized) | 29.5% | 28.5% |
| Max drawdown | -10.7% (Feb 2026→Mar 2026) | -64.6% (Oct 2021→Oct 2023) |

## Peers
GNOM (Global X Genomics & Biotechnolo) USD 65.58 -0.65% · IHAK (iShares Cybersecurity and Tech ) USD 74 +4.17% · IDRV (iShares Self-Driving EV and Tec) USD 30.37 -0.85% · XT (iShares Future Exponential Tech) USD 82.61 +0.28% · PBE (Invesco Biotechnology & Genome ) USD 98.72 -0.67%

## More
Full page: https://nexqual.com/IDNA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-12-18 | 56 | 34.6% | ±14.1% |
| 2027-03-19 | 147 | 37.8% | ±14.3% |